Newsletter

000100 - Yuhan Corporation

000100 Summary

Biopharma

Stock Price & Overview

₩80,000 +900 (+1.14%) Close · Sep 9, 2026 KST

KOSPI | ₩KRW | Close: ₩80,000 ≈ US$57 · Market cap ₩5.9tn (≈ $4.2bn)

Home › 000100 › Filings

Insider / Major Shareholder Holdings Report

DART

Yuhan Corporation

Filed Sep 9, 2026 KST · Ownership · receipt 20260909000122

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.

Korean form name: 임원ㆍ주요주주특정증권등소유상황보고서

000100

Price: ₩80,000
Change: +1.14%
Market cap: ₩5.9tn
Prev. close: ₩79,100

000100 Summary Compare to Peers

000100 data on kstock

Financials: 11 fiscal years
Valuation: Daily P/E, P/S, P/B, P/CF
Earnings: Eight quarters
Dividends: Per-share history

Every figure is taken from Yuhan Corporation's own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

kstock analysis on 000100

Yuhan: The $95m Order Comes From The Half Nobody Buys The Stock For

Sep 2, 1:26 AM

All 000100 analysis

More 000100 filings

000100 - Yuhan Corporation

Insider / Major Shareholder Holdings Report

000100

000100 data on kstock

kstock analysis on 000100

Yuhan: The $95m Order Comes From The Half Nobody Buys The Stock For

More 000100 filings

Investor Relations Event

Yuhan signs $95m API supply deal with an undisclosed global drugmaker

Serious industrial accident (subsidiary)

Fair-trade compliance programme status (notice)

Investor Relations Event

Half-Year Report